Federal health officials “violated unambiguous statutory commands” in 2018 when they lowered lower Medicare Part B drug reimbursement rates for 340B hospitals by nearly 30% and their decision should be set aside, hospital groups and individual hospitals told the U.S. Supreme Court last Friday.
The groups told the court on Sept. 3 that the Medicare statute does not preclude administrative or judicial review of the decision to cut 340B hospitals’ drug reimbursement. They also said a 1984 legal precedent about when courts should defer to federal agencies’ statutory interpretations “cannot justify” the U.S. Centers for Medicare & Medicaid Services’ (CMS) action.
Federal health officials “violated unambiguous statutory commands” in 2018 when they lowered lower Medicare Part B drug reimbursement rates for 340B hospitals by nearly 30% and their decision should be set aside, hospital groups and individual hospitals told the U.S. Supreme Court last Friday.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
